Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells
暂无分享,去创建一个
Fang Wang | Hong Zhang | Hongying Yang | C. Di | Yuhong Chen | Xuetian Zhang | G. Miao | Hongyan Li | Junfang Yan | Xiaohua Chen | Tuanjie Che | Xiaohua Chen | Caipeng Xu | Guo-ying Miao | Hong Zhang | Yuhong Chen | Tuanjie Che | Fang Wang | Hongying Yang
[1] Kankan Wang,et al. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia , 2020, Neoplasia.
[2] R. Reiter,et al. Melatonin: A new inhibitor agent for cervical cancer treatment , 2019, Journal of cellular physiology.
[3] D. Viñal,et al. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells) , 2019, Clinical and Translational Oncology.
[4] X. Su,et al. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome1 , 2019, Neoplasia.
[5] Hong Zhang,et al. Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells , 2019, Artificial cells, nanomedicine, and biotechnology.
[6] J. Hoheisel,et al. Function, clinical application, and strategies of Pre-mRNA splicing in cancer , 2018, Cell Death & Differentiation.
[7] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[8] R. Jia,et al. Splicing factor poly(rC)‐binding protein 1 is a novel and distinctive tumor suppressor , 2018, Journal of cellular physiology.
[9] Hui Li,et al. PCBP1 depletion promotes tumorigenesis through attenuation of p27Kip1 mRNA stability and translation , 2018, Journal of Experimental & Clinical Cancer Research.
[10] T. Ishii,et al. Specific binding of PCBP1 to heavily oxidized RNA to induce cell death , 2018, Proceedings of the National Academy of Sciences.
[11] Jun Chen,et al. MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma , 2018, Journal of experimental & clinical cancer research : CR.
[12] R. Barderas,et al. Clinical implications of the deregulated TP73 isoforms expression in cancer , 2018, Clinical and Translational Oncology.
[13] Yuanyu Wu,et al. Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis , 2017, Scientific Reports.
[14] D. Marzese,et al. TP73 DNA methylation and upregulation of ΔNp73 are associated with an adverse prognosis in breast cancer , 2017, Journal of Clinical Pathology.
[15] Xiaowu Li,et al. Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1 , 2017, International journal of oncology.
[16] D. Baralle,et al. RNA splicing in human disease and in the clinic. , 2017, Clinical science.
[17] Feng-Hou Gao,et al. Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression. , 2016, Biomedical reports.
[18] B. Liu,et al. Poly C binding protein 1 represses autophagy through downregulation of LC3B to promote tumor cell apoptosis in starvation. , 2016, The international journal of biochemistry & cell biology.
[19] A. Ganser,et al. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia. , 2015, Blood.
[20] Hong Zhang,et al. Diallyl disulfide attenuated carbon ion irradiation-induced apoptosis in mouse testis through changing the ratio of Tap73/ΔNp73 via mitochondrial pathway , 2015, Scientific Reports.
[21] Meifeng Zhou,et al. Downregulated Poly-C binding protein-1 is a novel predictor associated with poor prognosis in Acute Myeloid Leukemia , 2015, Diagnostic Pathology.
[22] Yifei Liu,et al. Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as a negative regulator of EMT and its clinical value. , 2015, International journal of clinical and experimental pathology.
[23] H. Gautrey,et al. Deregulation of splicing factors and breast cancer development. , 2015, Journal of molecular cell biology.
[24] N. Ferrari,et al. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression. , 2014, Cancer letters.
[25] P. Subramanian,et al. Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. , 2011, Cell metabolism.
[26] P. Howe,et al. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles. , 2010, RNA.
[27] J. Li,et al. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. , 2010, Cancer cell.
[28] Liujun Tang,et al. PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells , 2010, Molecular Cancer.
[29] M. Levrero,et al. The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting , 2009, Clinical Cancer Research.
[30] I. Jurisica,et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. , 2008, Genes & development.
[31] H. Loh,et al. Novel function of the poly(C)‐binding protein αCP3 as a transcriptional repressor of the mu opioid receptor gene , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] C. Hartmann,et al. MMP-13, p53 in the Progression of Malignant Peripheral Nerve Sheath Tumors , 2007 .
[33] H. Ngan,et al. Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73α , 2006, Molecular Cancer Therapeutics.
[34] J. Lawler,et al. Exercise training attenuates age‐induced elevation in Bax/Bcl‐2 ratio, apoptosis, and remodeling in the rat heart , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] G. Melino,et al. TAp73/ΔNp73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma , 2005, Cell Death and Differentiation.
[36] G. Melino,et al. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. , 2005, Cell death and differentiation.
[37] A. Chkheidze,et al. A Novel Set of Nuclear Localization Signals Determine Distributions of the αCP RNA-Binding Proteins , 2003, Molecular and Cellular Biology.
[38] A. Antony,et al. Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer , 2003, Journal of clinical pathology.
[39] U. Moll,et al. ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors , 2002, The Journal of experimental medicine.
[40] G. Melino,et al. p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.
[41] J. Eberle,et al. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. , 2001, The Journal of investigative dermatology.
[42] H. Leffers,et al. Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. , 1996, European journal of biochemistry.
[43] E. Smeland,et al. Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K. , 1994, Nucleic Acids Research.